Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9306081
[patent_doc_number] => 20140044755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF KRAS GENE'
[patent_app_type] => utility
[patent_app_number] => 13/943038
[patent_app_country] => US
[patent_app_date] => 2013-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22734
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943038
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/943038 | RNAi pharmaceutical composition for suppressing expression of KRAS gene | Jul 15, 2013 | Issued |
Array
(
[id] => 9108349
[patent_doc_number] => 20130281481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'SUBLINGUAL AND BUCCAL FILM COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/923749
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11985
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923749
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923749 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS | Jun 20, 2013 | Abandoned |
Array
(
[id] => 9517827
[patent_doc_number] => 20140154319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/924291
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11486
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13924291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/924291 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE | Jun 20, 2013 | Abandoned |
Array
(
[id] => 10262815
[patent_doc_number] => 20150147812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'CARRIER FOR GENE INTRODUCTION USE, GENE INTRODUCTION AGENT, METHODS FOR PRODUCING SAID CARRIER AND SAID GENE INTRODUCTION AGENT, AND METHOD FOR INTRODUCING GENE INTO CELL'
[patent_app_type] => utility
[patent_app_number] => 14/403957
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9913
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403957
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403957 | CARRIER FOR GENE INTRODUCTION USE, GENE INTRODUCTION AGENT, METHODS FOR PRODUCING SAID CARRIER AND SAID GENE INTRODUCTION AGENT, AND METHOD FOR INTRODUCING GENE INTO CELL | May 29, 2013 | Abandoned |
Array
(
[id] => 9197756
[patent_doc_number] => 20130337071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'RADIOFREQUENCY-INDUCED SYNCHRONIZATION OF IN SITU HYPERTHERMIA AND CHEMOTHERAPY VIA MAGNETIC-NANOCONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 13/905177
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6153
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905177
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/905177 | Radiofrequency-induced synchronization of in situ hyperthermia and chemotherapy via magnetic-nanoconjugates | May 29, 2013 | Issued |
Array
(
[id] => 10247397
[patent_doc_number] => 20150132393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'NANOSTRUCTURE COATED WITH A TWIST-STRAINED DOUBLE-STRANDED CIRCULAR DEOXYRIBONUCLEIC|ACID (DNA), METHOD FOR MAKING AND USE'
[patent_app_type] => utility
[patent_app_number] => 14/397834
[patent_app_country] => US
[patent_app_date] => 2013-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9109
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397834 | NANOSTRUCTURE COATED WITH A TWIST-STRAINED DOUBLE-STRANDED CIRCULAR DEOXYRIBONUCLEIC|ACID (DNA), METHOD FOR MAKING AND USE | Apr 25, 2013 | Abandoned |
Array
(
[id] => 9771256
[patent_doc_number] => 20140294919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/870762
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9689
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870762
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870762 | VACCINES | Apr 24, 2013 | Abandoned |
Array
(
[id] => 9262067
[patent_doc_number] => 20130343996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'GRAPHITE-COATED MAGNETIC NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/870625
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7271
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870625
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870625 | GRAPHITE-COATED MAGNETIC NANOPARTICLES | Apr 24, 2013 | Abandoned |
Array
(
[id] => 15160823
[patent_doc_number] => 10485884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => RNA formulation for immunotherapy
[patent_app_type] => utility
[patent_app_number] => 14/388192
[patent_app_country] => US
[patent_app_date] => 2013-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 27303
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388192 | RNA formulation for immunotherapy | Mar 24, 2013 | Issued |
Array
(
[id] => 9280351
[patent_doc_number] => 20140030319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers'
[patent_app_type] => utility
[patent_app_number] => 13/835524
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10640
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835524
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/835524 | Antagonists Of The Oncongenic Activity Of The Protein MDM2, And Use Thereof In the Treatment of Cancers | Mar 14, 2013 | Abandoned |
Array
(
[id] => 11342317
[patent_doc_number] => 09526702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Vaccine nanotechnology'
[patent_app_type] => utility
[patent_app_number] => 13/844258
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 83
[patent_no_of_words] => 68750
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/844258 | Vaccine nanotechnology | Mar 14, 2013 | Issued |
Array
(
[id] => 10064117
[patent_doc_number] => 09102950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Compositions and methods for enhancing immune responses to vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/835806
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26275
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13835806
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/835806 | Compositions and methods for enhancing immune responses to vaccines | Mar 14, 2013 | Issued |
Array
(
[id] => 10911849
[patent_doc_number] => 20140314865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'Vaccine Nanotechnology'
[patent_app_type] => utility
[patent_app_number] => 13/844382
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 68736
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844382
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/844382 | Vaccine nanotechnology | Mar 14, 2013 | Issued |
Array
(
[id] => 11697651
[patent_doc_number] => 09687548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/395210
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 16443
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395210 | Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof | Mar 13, 2013 | Issued |
Array
(
[id] => 9823512
[patent_doc_number] => 08932993
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-01-13
[patent_title] => 'Method of testing for endometriosis and treatment therefor'
[patent_app_type] => utility
[patent_app_number] => 13/788913
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41581
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13788913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/788913 | Method of testing for endometriosis and treatment therefor | Mar 6, 2013 | Issued |
Array
(
[id] => 9844212
[patent_doc_number] => 08946127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms'
[patent_app_type] => utility
[patent_app_number] => 13/784121
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 9623
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13784121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/784121 | Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms | Mar 3, 2013 | Issued |
Array
(
[id] => 9699518
[patent_doc_number] => 20140249203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/782486
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 32087
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782486
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782486 | Nanoparticles stabilized with nitrophenylboronic acid compositions | Feb 28, 2013 | Issued |
Array
(
[id] => 11242654
[patent_doc_number] => 09468681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Targeted nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/782458
[patent_app_country] => US
[patent_app_date] => 2013-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 33499
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/782458 | Targeted nanoparticles | Feb 28, 2013 | Issued |
Array
(
[id] => 9003136
[patent_doc_number] => 20130224261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'ENVIRONMENTALLY-RESPONSIVE NANOCOMPOSITES AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/770943
[patent_app_country] => US
[patent_app_date] => 2013-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 26612
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13770943
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/770943 | ENVIRONMENTALLY-RESPONSIVE NANOCOMPOSITES AND METHODS OF THEIR USE | Feb 18, 2013 | Abandoned |
Array
(
[id] => 10627671
[patent_doc_number] => 09345810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Liquefaction of bone matrix'
[patent_app_type] => utility
[patent_app_number] => 14/377272
[patent_app_country] => US
[patent_app_date] => 2013-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16956
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377272
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377272 | Liquefaction of bone matrix | Feb 6, 2013 | Issued |